Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Serous Adenocarcinoma 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Transcriptome × Clear all
NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

GOG Foundation

Completed
360 enrolled
Gynecologic

Endometrial Serous Adenocarcinoma

NCT03409692 2023-06-29

MMpredict

University of Turin, Italy

Completed
278 enrolled
Plasma cell

Multiple Myeloma

NCT05318391 2022-04-08

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Shanghai Zhongshan Hospital

Completed
324 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡